Cohance Lifesciences Limited (NSE:COHANCE)
India
· Delayed Price · Currency is INR 542.55
-6.55 (-1.19%)
At close: Dec 5, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 207.56 billion as of December 5, 2025. Its market cap has decreased by -36.35% in one year.
Market Cap
207.56B
Enterprise Value
209.43B
Revenue
12.11B
Ranking
n/a
PE Ratio
78.87
Stock Price
542.55
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 207.56B, an increase of 615,719.02%. That is a compound annual growth rate of 356.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 207.56B | -28.40% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,334.88B |
| Divi's Laboratories | 1,713.60B |
| Cipla | 1,225.07B |
| Apollo Hospitals Enterprise | 1,032.95B |
| Zydus Lifesciences | 940.78B |
| Mankind Pharma | 910.38B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |